Viral Inactivation Market By Product Type (Viral Inactivation Systems, Kits & Reagents, Accessories, and Services), By Method (Pasteurization, Solvent Detergents, and Others), By Application Type (Blood & blood products, Tissue & tissue products, Vaccines and therapeutic, Cellular &gene therapy products, Stem cell products and Others), By End User (Pharmaceutical and biotechnology companies, Contract research organizations, Academic research institutes, and Others) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Viral Inactivation Market size was valued at USD 2.1 billion in 2022 and is poised to grow at a CAGR of 12.8% from 2023-2029. Viral inactivation is a viral removal process in which the viruses may persist in the final product but in an ineffective arrangement. Viral inactivation is a vital part of the viral clearing process and is used for all categories of pharmaceutical drugs. As a result, the market for Viral Inactivation is given a chance to expand due to the growing acceptance of the Viral Inactivation Process.

Additionally, the market is anticipated to rise as more healthcare facilities start to offer a virus-clearing process. Viral Inactivation process acceptance, medical professionals' choice of advanced products, rising healthcare costs, and rising prevalence of chronic diseases are the principal factors boosting the global market growth. Increasing acceptance day by day with the finest pricing is a significant growth driver. With the rising incidence of diseases, medical technology advancements, and investments in R&D activities, the pharmaceutical and healthcare industries have recently undergone significant changes. Public and private sector funding in medical research for medication discovery advancements will expand the market for viral inactivation. Market growth exponentially increased during the COVID-19 pandemic due, to research related to many kinds of viruses. Somehow, after the pandemic market growth is hampered, but with further investment in the advancement of healthcare sectors, this market growth will revive soon.

Viral Inactivation Market Key Developments:

In May 2021, Pharma's Almanac launched continuous inline viral inactivation for next-generation bioprocessing.
In March 2022, Thermo Fisher Scientific launched a new non-hazardous viral inactivation medium that supports the safe collection and transport of SARS-COV-2.

Viral Inactivation Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

12.8%

Largest Market

Asia-Pacific

Fastest Growing Market

North America
Viral Inactivation Market Dynamics

The significant driving factor for the viral inactivation market is the increasing approvals of new drugs and instructions related to the viral safety of biologics. Also, the market for Viral Inactivation is growing due to the continuous increment of various infectious diseases and the rising application of biosimilar therapeutic treatments for many diseases. The industry's expansion is mainly related to increasing investments in pharmaceutical and biotech companies and rising demand for various vaccines and biotherapy agents. However, the market is constrained by the high cost associated with technology for virus clearing methods.

Viral Inactivation Market Segmentation

By Product Type
  • Kits and reagents
  • Viral inactivation systems
  • Services
  • Accessories
By Application
  • Blood & blood products
  • Tissue & tissue products
  • Vaccines and therapeutic
  • Cellular & gene therapy products
  • Stem cell products
  • Others
By End User
  • Pharmaceutical and biotechnology companies
  • Contract research organizations
  • Academic research institutes
  • Others

Frequently Asked Questions

The viral inactivation market is projected to expand at a CAGR of 12.8% during the forecast period

Parker Hannifin (U.S.), Clean Cells (France), Sartorius AG (Germany), Danaher Corporation (U.S.), Merck KGaA (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France)

North America is the fastest-growing region for viral inactivation market

Key Features of the Reports

  • The viral inactivation market report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1. Executive Summary
2. Global Viral Inactivation Market Introduction
2.1. Global Viral Inactivation Market Taxonomy
2.2. Global Viral Inactivation Market Definitions
2.2.1. Product Type
2.2.2. Method Type
2.2.3. Application
2.2.4. End User
2.2.5. Geography
3. Global Viral Inactivation Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Viral Inactivation Market Dynamic Factors - Impact Analysis
3.6. Global Viral Inactivation Market Competition Landscape
4. Global Viral Inactivation Market Analysis,2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Viral Inactivation Market, By Product Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.  Kits, & Reagents
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Viral Inactivation Systems
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Services
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Accessories
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Global Viral Inactivation Market, By Method Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1. Pasteurization
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Solvent Detergents
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Others
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Viral Inactivation Market Forecast, By Application, 2018 - 2022and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1. Blood & Blood Products
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Tissue & tissue Products
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Stem Cell Products
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Cellular & gene therapy Products
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Vaccines & therapeutic
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Others
7.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
8. Global Viral Inactivation Market Forecast, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1. Pharmaceutical and biotechnology companies
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Contract research organizations
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Academic research institutes
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Others
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global Viral Inactivation Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029(Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Viral Inactivation Market - Opportunity Analysis Index, By Product Type, Method Type, Application, End User and Region, 2023 - 2029
10. North America Viral Inactivation Market Analysis,2018 - 2022 and Forecast, 2023 - 2029(Revenue, USD Mn)
10.1. Product Type Analysis 2018 - 2022and Forecast 2023 - 2029by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Viral inactivation systems
10.1.2. Services
10.1.3.  Kits and reagents
10.1.4.  Accessories
10.2. Method Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Pasteurization
10.2.2. Solvent Detergents
10.2.3. Others
10.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Blood & blood products
10.3.2.  Tissue & tissue products
10.3.3.  Vaccines and therapeutic
10.3.4.  Cellular & gene therapy products
10.3.5. Stem cell products
10.3.6. Others
10.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Pharmaceutical and biotechnology companies
10.4.2.  Contract research organizations
10.4.3.  Academic research institutes
10.4.4.  Others
10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Viral Inactivation Market - Opportunity Analysis Index, By Product Type, Method Type, Application, End User and Country, 2023 - 2029
10.7. North America Viral Inactivation Market Dynamics Trends
11. Europe Viral Inactivation Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
11.1. Product Type Analysis 2018 - 2022and Forecast 2023 - 2029by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Viral inactivation systems
11.1.2. Services
11.1.3.  Kits and reagents
11.1.4.  Accessories
11.2. Method Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Pasteurization
11.2.2. Solvent Detergents
11.2.3. Others
11.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Blood & blood products
11.3.2.  Tissue & tissue products
11.3.3.  Vaccines and therapeutic
11.3.4.  Cellular & gene therapy products
11.3.5. Stem cell products
11.3.6. Others
11.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Pharmaceutical and biotechnology companies
11.4.2.  Contract research organizations
11.4.3.  Academic research institutes
11.4.4.  Others
11.5. Country Analysis 2018 - 2022and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Viral Inactivation Market - Opportunity Analysis Index, By Product Type, Method Type, Application, End User and Country, 2023 - 2029
11.7. Europe Viral Inactivation Market Dynamics Trends
12. Asia-Pacific Viral Inactivation Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
12.1. Product Type Analysis 2018 - 2022and Forecast 2023 - 2029by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Viral inactivation systems
12.1.2. Services
12.1.3.  Kits and reagents
12.1.4.  Accessories
12.2. Method Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Pasteurization
12.2.2. Solvent Detergents
12.2.3. Others
12.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Blood & blood products
12.3.2.  Tissue & tissue products
12.3.3.  Vaccines and therapeutic
12.3.4.  Cellular & gene therapy products
12.3.5. Stem cell products
12.3.6. Others
12.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Pharmaceutical and biotechnology companies
12.4.2. Contract research organizations
12.4.3. Academic research institutes
12.4.4. Others
12.5. Country Analysis2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Viral Inactivation Market - Opportunity Analysis Index, By Product Type, Method Type, Application, End User and Country,2023 - 2029
12.7. Asia-Pacific Viral Inactivation Market Dynamics Trends
13. Latin America Viral Inactivation Market Analysis 2018 - 2022 and Forecast, 2023 - 2029(Revenue, USD Mn)
13.1. Product Type Analysis 2018 - 2022and Forecast 2023 - 2029by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Viral inactivation systems
13.1.2. Services
13.1.3.  Kits and reagents
13.1.4.  Accessories
13.2. Method Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Pasteurization
13.2.2. Solvent Detergents
13.2.3. Others
13.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Blood & blood products
13.3.2.  Tissue & tissue products
13.3.3.  Vaccines and therapeutic
13.3.4.  Cellular & gene therapy products
13.3.5. Stem cell products
13.3.6. Others
13.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Pharmaceutical and biotechnology companies
13.4.2.  Contract research organizations
13.4.3.  Academic research institutes
13.4.4.  Others
13.5. Country Analysis 2018 - 2022and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Rest of Latin America
13.6. Latin America Viral Inactivation Market - Opportunity Analysis Index, By Product Type, Method Type, Application, Disease Type, End User and Country, 2023 - 2029
13.7. Latin America Viral Inactivation Market Dynamics Trends
14. Middle East and Africa Viral Inactivation Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.1. Product Type Analysis 2018 - 2022and Forecast 2023 - 2029by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Viral inactivation systems
14.1.2. Services
14.1.3.  Kits and reagents
14.1.4.  Accessories
14.2. Method Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Pasteurization
14.2.2. Solvent Detergents
14.2.3. Others
14.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Blood & blood products
14.3.2.  Tissue & tissue products
14.3.3.  Vaccines and therapeutic
14.3.4.  Cellular & gene therapy products
14.3.5. Stem cell products
14.3.6. Others
14.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Pharmaceutical and biotechnology companies
14.4.2.  Contract research organizations
14.4.3.  Academic research institutes
14.4.4.  Others
14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Viral Inactivation Market - Opportunity Analysis Index, By Product Type, Method Type, Application, Disease Type, End User and Country, 2023 - 2029
14.7. MEA Viral Inactivation Market Dynamics Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product Type& Service Testing Types, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Parker Hannifin (U.S.)
15.2.2.  Clean Cells (France)
15.2.3.  Charles River Laboratories International, Inc. (U.S.)
15.2.4.  Sartorius AG (Germany)
15.2.5.  Danaher Corporation (U.S.)
15.2.6.  Merck KGaA (Germany)
15.2.7.  SGS S.A. (Switzerland)
15.2.8.  Texcell, Inc. (France)
15.2.9.  Viral Inactivated Plasma Systems SA (Switzerland)
15.2.10.   WuXi PharmaTech (Cayman) Inc. (China)
15.2.11.  Rad Source Technologies (U.S.)
16. Research Methodology
17. Key Assumptions and Acronyms
  • Parker Hannifin (U.S.)
  • Clean Cells (France)
  • Charles River Laboratories International, Inc. (U.S.)
  • Sartorius AG (Germany)
  • Danaher Corporation (U.S.)
  • Merck KGaA (Germany)
  • SGS S.A. (Switzerland)
  • Texcell, Inc. (France)
  • Viral Inactivated Plasma Systems SA (Switzerland)
  • WuXi PharmaTech (Cayman) Inc. (China)
  • Rad Source Technologies (U.S.)

Adjacent Markets